...
首页> 外文期刊>Ancient Science of Life >PA03.02. The effect of bhumyamalaki (Phyllanthus Niruri) in balatisara with special reference to viral diarrhea
【24h】

PA03.02. The effect of bhumyamalaki (Phyllanthus Niruri) in balatisara with special reference to viral diarrhea

机译:PA03.02。 bhumyamalaki(Phyllanthus Niruri)在巴拉蒂萨拉的效果,特别涉及病毒性腹泻

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Balatisara is one of the commonest diseases in developing countries like India. There are 5 billion episodes of diarrhea every year out of which 3.5 million children die. Bhumyamalaki is known for its antiviral activity, 90 % of infantile diarrheas are due to some enteroviruses. Therefore the present research work was planned to evaluate the effect of Bhumyamalaki syrup. Method: The present study was conducted on 30children presenting with viral diarrhea in between the age group of 1 to 10 years.The patients were selected from S.D.M.C.A & Hospital, Hassan.They were divided into two groups with 15 children in each group, viz. Group B (Bhumyamalaki syrup) and Group S (sugar syrup as placebo). The syrup was given in a dose of 5ml and 10ml for the age group 1to 5 years and 5 to 10 years four times a day for 7 days respectively. The cases were recorded according to the case proforma prepared for the study and observations were graded according to the gradation chart prepared. Result: Bhumyamalaki Syrup provided significant relief in the symptoms of viral diarrhea such as Malavega (73.19%), consistency (67.48%), fever (88.49%),vomiting (89.24%), abdominal pain (89.68%), loss of appetite (95%) and dehydration (95.89%). In this group, 73.33% and 26.67% patients showed marked and moderate improvements respectively. Sugar syrup provided relief in the symptoms such as Malavega (36.84%), Consistency (45.39%), Fever (67.14%), Vomiting (74.27%), Abdominal Pain (75.90%), Appetite (74%) and Dehydration (85.71%).In this group, 53.33% and 46.67% patients showed moderate and mild improvements respectively. Conclusion: Bhumyamalaki Syrup provided better relief in comparison to sugar syrup in the symptoms of Mala Vega, consistency, fever, vomiting, abdominal pain, appetite and dehydration.
机译:目的:Balatisara是印度等发展中国家最常见的疾病之一。每年有50亿腹泻发作,其中350万儿童死亡。 Bhumyamalaki以其抗病毒活性而闻名,90%的婴儿腹泻是由于某些肠病毒引起的。因此,目前的研究工作被计划为评估普玛山拉奇糖浆的效果。方法:本研究针对1至10岁年龄段的30例病毒性腹泻患儿进行了研究,他们来自哈桑(S.D.M.C.A)和哈桑(Hossan)医院,分为两组,每组15名儿童。 B组(Bhumyamalaki糖浆)和S组(糖浆作为安慰剂)。糖浆剂的剂量分别为1至5岁和5至10岁年龄组,分别为5毫升和10毫升,每天服用4天,共7天。根据为研究准备的病例表记录病例,并根据准备的分级表对观察结果进行分级。结果:普罕玛拉奇糖浆可明显缓解病毒性腹泻症状,如马拉维加(73.19%),稠度(67.48%),发烧(88.49%),呕吐(89.24%),腹痛(89.68%),食欲不振( 95%)和脱水(95.89%)。在这一组中,分别有73.33%和26.67%的患者表现出明显的改善和中度改善。糖浆缓解了马拉维加(36.84%),稠度(45.39%),发烧(67.14%),呕吐(74.27%),腹痛(75.90%),食欲(74%)和脱水(85.71%)等症状在该组中,分别有53.33%和46.67%的患者表现出中度和轻度改善。结论:相比于糖浆,Bhumyamalaki糖浆在Mala Vega,稠度,发烧,呕吐,腹痛,食欲和脱水的症状上提供了更好的缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号